Bruno Brochet Selected Research

Bruno Brochet Research Topics

Disease

21	Multiple Sclerosis 04/2024 - 01/2002
3	Relapsing-Remitting Multiple Sclerosis 01/2019 - 02/2016
2	Disease Progression 01/2021 - 12/2020
2	Chronic Progressive Multiple Sclerosis 12/2020 - 01/2017
2	Infections 12/2020 - 01/2020
2	Myelitis 01/2020 - 01/2012
2	Progressive Multifocal Leukoencephalopathy 12/2016 - 09/2013
2	Cognitive Dysfunction 04/2016 - 12/2015
2	Brain Neoplasms (Brain Tumor) 12/2015 - 10/2004
2	Edema (Dropsy) 10/2011 - 08/2011
2	Demyelinating Diseases (Demyelinating Disease) 09/2008 - 01/2002
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	COVID-19 01/2020
1	Transverse Myelitis (Necrotizing Myelitis) 01/2020
1	Dementia (Dementias) 01/2018
1	Fatigue 11/2017
1	Optic Neuritis (Retrobulbar Neuritis) 10/2017
1	Neuromyelitis Optica (Devic's Disease) 09/2017
1	Alzheimer Disease (Alzheimer's Disease) 04/2016
1	Glioma (Gliomas) 12/2015
1	Leukoencephalopathies 01/2012
1	Cicatrix (Scar) 10/2011
1	Encephalitis (Encephalitis, Rasmussen) 10/2011
1	Inflammation (Inflammations) 10/2011
1	Gliosis 10/2011
1	Hydrocephalus (Hydrocephaly) 08/2009
1	Neoplasms (Cancer) 10/2004
1	Brain Infarction 10/2004
1	Stroke (Strokes) 10/2004
1	Atherosclerotic Plaque (Atheroma) 10/2004
1	Abnormal Reflex (Hyperreflexia) 01/2004
1	Chronic Pain 06/2003
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2002

Drug/Important Bio-Agent (IBA)

5	Natalizumab (Tysabri)FDA Link 11/2017 - 09/2013
3	ocrelizumabIBA 04/2024 - 01/2020
3	AntibodiesIBA 01/2020 - 01/2002
3	Biomarkers (Surrogate Marker)IBA 12/2015 - 10/2004
2	Cladribine FDA LinkGeneric 12/2023 - 01/2022
2	TabletsIBA 12/2023 - 01/2022
2	teriflunomideIBA 01/2022 - 01/2019
2	Dimethyl FumarateIBA 01/2022 - 01/2019
2	Immunoglobulin G (IgG)IBA 09/2017 - 08/2011
2	Fingolimod Hydrochloride (FTY720)FDA Link 02/2016 - 04/2014
2	Contrast MediaIBA 07/2012 - 10/2004
2	GadoliniumIBA 07/2012 - 08/2011
2	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 07/2012 - 10/2004
2	Aquaporin 4IBA 10/2011 - 08/2009
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 08/2020
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Interferon-betaIBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017
1	Methylprednisolone FDA LinkGeneric 01/2017
1	Biotin (Vitamin H)FDA Link 11/2016
1	Memantine (Namenda)FDA Link 04/2016
1	N-Methylaspartate (NMDA)IBA 04/2016
1	Glutamate Receptors (Glutamate Receptor)IBA 04/2016
1	Temozolomide (Temodar)FDA LinkGeneric 12/2015
1	SteroidsIBA 08/2012
1	ferric oxide (iron oxide)IBA 07/2012
1	Oligoclonal BandsIBA 01/2012
1	InterleukinsIBA 10/2011
1	Aquaporins (Water Channels)IBA 10/2011
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 10/2011
1	CytokinesIBA 08/2011
1	CuprizoneIBA 09/2008
1	Capsaicin (Zostrix)FDA Link 01/2004
1	resiniferatoxinIBA 01/2004
1	Analgesics (Analgesic Drugs)IBA 06/2003
1	S-nitrosocysteineIBA 01/2002
1	Cysteine (L-Cysteine)FDA Link 01/2002
1	Myelin Basic ProteinIBA 01/2002
1	Peptides (Polypeptides)IBA 01/2002

Therapy/Procedure

8	Therapeutics 01/2021 - 09/2017
1	Injections 01/2022
1	Cognitive Training 12/2021
1	Castration 01/2021
1	Plasma Exchange 08/2020
1	Tertiary Prevention 01/2018
1	Radiotherapy 12/2015
1	Drug Therapy (Chemotherapy) 12/2015